Question 16969 — maternity health insurance

Summary

Ms. Sabine Rubin questions the Minister of Solidarity and Health about the creation of a special fund for victims of androcur marketed by Bayer laboratories. Cyproterone acetate, androcur and its generics, is a progestogen prescribed in cases of hair disorders, excess sebum but also in cases of prostate cancer. It is particularly prescribed for women. A recent study of pharmacoepidemiology carried out by health insurance in collaboration with the neurosurgery department of Lariboisière hospital, showed that this medication significantly increases the risk of meningioma, a brain tumor that is most often benign but highly disabling, since it causes exophthalmia, epilepsy, language disorders, dizziness, headaches, walking, memory, hearing and vision problems. etc. This tumor is not always operable. Already in 2009, France issued a signal at European level on the risk of the appearance of meningioma. In August 2018, the ANSM itself asked healthcare professionals to inform patients about the risk of meningioma. Since 2015, 500 cases of operated meningiomas have been recorded by the CNAM, but many other victims have not made a report due to lack of awareness of this device. Cases of unoperated meningiomas are not recorded. These victims of androcur group together into different collectives and are disarmed and destitute. She would like to know if, like what was put in place for the victims of the pick and depakine, a compensation fund will be set up to compensate these people for the damage suffered.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.